P2X7 receptor‐stimulation causes fever via PGE2 and IL‐1β release
Open accessAbstract
Prostaglandins (PGs) are important lipid mediators involved in the development of inflammatory associated pain and fever. PGE2 is a well‐established endogenous pyrogen activated by proinflammatory cytokine interleukin (IL)‐1β. P2X7 receptors (P2X7Rs) expressed by inflammatory cells are stimulated by the danger signal extracellular ATP to activate the inflammasome and release IL‐1β. Here we show that P2X7R activation is required for the release of PGE2 and other autacoids independent of inflammasome activation, with an ATP EC 50 for PGE2 and IL‐1β release of 1.58 and 1.23 mM, respectively. Furthermore, lack of P2X7R or specific antagonism of P2X7R decreased the febrile response in mice triggered after intraperitoneal LPS or IL‐1β inoculation. Accordingly, LPS inoculation caused intraperitoneal ATP accumulation. Therefore, P2X7R antagonists emerge as novel therapeutics for the treatment for acute inflammation, pain and fever, with wider anti‐inflammatory activity than currently used cyclooxygenase inhibitors.—Barberà‐Cremades, M., Baroja‐Mazo, A., Gomez, A. I., Machado, F., Di Virgilio, F., Pelegrín, P. P2X7 receptor‐stimulation causes fever via PGE2 and IL‐1β release. FASEB J. 26, 2951–2962 (2012). www.fasebj.org
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In a disease state such as infection or brain disease, extracellular ATP levels largely increase and activate P2X7 receptors.
“Conversely, in a disease state as infection or brain disease, extracellular ATP levels largely increase and activate P2X7 receptors [68–70].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [70]
The role of P2X7 receptor as a modulator of inflammatory response is well-established.
“In fact, the role of P2X7 receptor as a modulator of inflammatory response is well-established [16, 70].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [70]
Cites
Molecular Physiology of P2X Receptors
North, R. A. (2002) · Physiological Reviews · doi:10.1152/physrev.00015.2002 · Cited by 2,919 · see citing works
The role of cyclooxygenases in inflammation, cancer, and development
Williams, C. S., Mann, M., & DuBois, R. N. (1999) · Oncogene · doi:10.1038/sj.onc.1203286 · Cited by 1,417 · see citing works
The P2X7 Receptor: A Key Player in IL-1 Processing and Release
Ferrari, D., Pizzirani, C., Adinolfi, E., Lemoli, R. M., Curti, A., Idzko, M., Panther, E., & Di Virgilio, F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.3877 · Cited by 1,025 · see citing works
Altered Cytokine Production in Mice Lacking P2X7Receptors
Solle, M., Labasi, J. M., Perregaux, D. G., Stam, E. J., Petrushova, N., Koller, B. H., Griffiths, R., & Gabel, C. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006781200 · Cited by 924 · see citing works
Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain
Chessell, I. P., Hatcher, J. P., Bountra, C., Michel, A. D., Hughes, J. P., Green, P., Egerton, J., Murfin, M., Richardson, J. C., Peck, W. L., et al. (2005) · Pain · doi:10.1016/j.pain.2005.01.002 · Cited by 790 · see citing works
Netea, M. G., Nold‐Petry, C. A., Nold, M. F., Joosten, L. A. B., Opitz, B., van der Meer, J. H. M., van de Veerdonk, F. L., Ferwerda, G., Heinhuis, B., Devesa, I., et al. (2008) · Blood · doi:10.1182/blood-2008-03-146720 · Cited by 787 · see citing works
Increased Level of Extracellular ATP at Tumor Sites: In Vivo Imaging with Plasma Membrane Luciferase
Pellegatti, P., Raffaghello, L., Bianchi, G., Piccardi, F., Pistoia, V., & Di Virgilio, F. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002599 · Cited by 668 · see citing works
Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells
Idzko, M., Hammad, H., van Nimwegen, M., Kool, M., Willart, M. A. M., Muskens, F., Hoogsteden, H. C., Luttmann, W., Ferrari, D., Virgilio, F. D., et al. (2007) · Nature Medicine · doi:10.1038/nm1617 · Cited by 620 · see citing works
Ulmann, L., Hatcher, J. P., Hughes, J. P., Chaumont‐Dubel, S., Green, P. J., Conquet, F., Buell, G. N., Reeve, A. J., Chessell, I. P., & Rassendren, F. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.2308-08.2008 · Cited by 549 · see citing works
Pharmacological profiles of cloned mammalian P2Y-receptor subtypes
von Kügelgen, I. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.08.014 · Cited by 541 · see citing works
Anti-Inflammatory Drugs in the 21st Century
Rainsford, K. D. (2007) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/1-4020-5688-5_1 · Cited by 465 · see citing works
Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R
Wilhelm, K., Ganesan, J., Müller, T., Dürr, C., Grimm, M., Beilhack, A., Krempl, C. D., Sorichter, S., Gerlach, U. V., Jüttner, E., et al. (2010) · Nature Medicine · doi:10.1038/nm.2242 · Cited by 435 · see citing works
Hunot, S., Vila, M., Teismann, P., Davis, R. J., Hirsch, É. C., Przedborski, S., RAKIC, P. T., & Flavell, R. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307453101 · Cited by 427 · see citing works
Portanova, J. P., Zhang, Y., Anderson, G., Hauser, S. D., Masferrer, J. L., Seibert, K., Gregory, S. A., & Isakson, P. C. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.3.883 · Cited by 421 · see citing works
Honoré, P., Donnelly‐Roberts, D. L., Namovic, M. T., Hsieh, G. C., Zhu, C., Mikusa, J. P., Hernandez, G., Zhong, C., Gauvin, D. M., Chandran, P., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.111559 · Cited by 418 · see citing works
P2X7 Receptor Differentially Couples to Distinct Release Pathways for IL-1β in Mouse Macrophage
Pelegrı́n, P., Barroso-Gutierrez, C., & Surprenant, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7147 · Cited by 413 · see citing works
Self-citationExtracellular ATP Is a Danger Signal Activating P2X7 Receptor in Lung Inflammation and Fibrosis
Riteau, N., Gasse, P., Fauconnier, L., Gombault, A., Couegnat, M., Fick, L., Kanellopoulos, J., Quesniaux, V. F. J., Marchand-Adam, S., Crestani, B., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201003-0359oc · Cited by 397 · see citing works
Multiple biological activities of human recombinant interleukin 1.
Dinarello, C. A., Cannon, J. G., Mier, J. W., Bernheim, H. A., LoPreste, G., Lynn, D., Love, R. N., Webb, A. C., Auron, P. E., & Reuben, R. C. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112495 · Cited by 366 · see citing works
Cao, C., Matsumura, K., Yamagata, K., & Watanabe, Y. (1996) · Brain Research · doi:10.1016/0006-8993(96)00575-6 · Cited by 308 · see citing works
Autocrine regulation of T‐cell activation by ATP release and P2X 7 receptors
Yip, L., Woehrle, T., Corriden, R., Hirsh, M., Chen, Y., Inoue, Y., Ferrari, V., Insel, P. A., & JUNGER, W. G. (2009) · The FASEB Journal · doi:10.1096/fj.08-126458 · Cited by 284 · see citing works
Arulkumaran, N., Unwin, R. J., & Tam, F. W. K. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.578068 · Cited by 241 · see citing works
Prostaglandin E2 as a mediator of fever: synthesis and catabolism
Andrei, I. I. (2004) · Frontiers in bioscience · doi:10.2741/1383 · Cited by 239 · see citing works
Prostanoids and pain: unraveling mechanisms and revealing therapeutic targets
Samad, T. A., Sapirstein, A., & Woolf, C. J. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02383-3 · Cited by 229 · see citing works
P2X4 receptors mediate PGE2 release by tissue‐resident macrophages and initiate inflammatory pain
Ulmann, L., Hirbec, H., & Rassendren, F. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.126 · Cited by 229 · see citing works
Gijón, M. A., Spencer, D. M., Siddiqi, A. R., Bonventre, J. V., & Leslie, C. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m908941199 · Cited by 219 · see citing works
Lack of the purinergic receptor P2X7 results in resistance to contact hypersensitivity
Weber, F. C., Esser, P. R., Müller, T., Ganesan, J., Pellegatti, P., Simon, M. M., Zeiser, R., Idzko, M., Jakob, T., & Martin, S. F. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20092489 · Cited by 209 · see citing works
Kuroda, E., Ishii, K. J., Uematsu, S., Ohata, K., Coban, C., Akira, S., Aritake, K., Urade, Y., & Morimoto, Y. (2011) · Immunity · doi:10.1016/j.immuni.2011.03.019 · Cited by 208 · see citing works
Panupinthu, N., Rogers, J. T., Zhao, L., Solano-Flores, L. P., Possmayer, F., Sims, S. M., & Dixon, S. J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200708037 · Cited by 175 · see citing works
Pseudoapoptosis Induced by Brief Activation of ATP-gated P2X7 Receptors
Mackenzie, A. B., Young, M. T., Adinolfi, E., & Surprenant, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502705200 · Cited by 174 · see citing works
Donnelly‐Roberts, D. L., McGaraughty, S., Shieh, C., Honoré, P., & Jarvis, M. F. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.105890 · Cited by 170 · see citing works
Brough, D., Feuvre, R. A. L., Wheeler, R. D., Solovyova, N. A., Hilfiker, S., Rothwell, N. J., & Verkhratsky, A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.3029 · Cited by 168 · see citing works
Selective COX-2 Inhibitors and Dual Acting Anti-inflammatory Drugs: Critical Remarks
Bertolini, A., Ottani, A., & Sandrini, M. (2002) · Current Medicinal Chemistry · doi:10.2174/0929867024606650 · Cited by 158 · see citing works
Inhibition of Chlamydial Infectious Activity due to P2X7R-Dependent Phospholipase D Activation
Coutinho‐Silva, R., Welter-Stahl, L., Raymond, M., Jungas, T., Verbeke, P., Burnstock, G., Darville, T. L., & Ojcius, D. M. (2003) · Immunity · doi:10.1016/s1074-7613(03)00235-8 · Cited by 157 · see citing works
P2X7 receptor activation induces CXCL2 production in microglia through NFAT and PKC/MAPK pathways
Shiratori, M., Tozaki‐Saitoh, H., Yoshitake, M., Tsuda, M., & Inoue, K. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06809.x · Cited by 153 · see citing works
Regulation of prostaglandin endoperoxide synthase (cyclooxygenase) isozyme expression
Goppelt‐Struebe, M. (1995) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/0952-3278(95)90039-x · Cited by 134 · see citing works
López‐Castejón, G., Theaker, J., Pelegrı́n, P., Clifton, A. D., Braddock, M., & Surprenant, A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000436 · Cited by 126 · see citing works
Self-citationProstaglandin E2, an Immunoactivator
Sakata, D., Yao, C., & Narumiya, S. (2010) · Journal of Pharmacological Sciences · doi:10.1254/jphs.09r03cp · Cited by 126 · see citing works
Gudipaty, L., Humphreys, B. D., Buell, G. N., & Dubyak, G. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.4.c943 · Cited by 117 · see citing works
Honoré, P., Donnelly‐Roberts, D. L., Namovic, M. T., Zhong, C., Wade, C. L., Chandran, P., Zhu, C., Carroll, W. A., Perez‐Medrano, A., Iwakura, Y., et al. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.05.018 · Cited by 116 · see citing works
Donnelly‐Roberts, D. L., Namovic, M. T., Faltynek, C. R., & Jarvis, M. F. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.059600 · Cited by 114 · see citing works
Cyclooxygenase-2 mediates the febrile response of mice to interleukin-1β
Li, S., Ballou, L. R., Morham, S. G., & Blatteis, C. M. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02707-x · Cited by 105 · see citing works
Alzola, E., Pérez-Etxebarria, A., Kabré, E., Fogarty, D. J., Métioui, M., Chaı̈b, N., Macarulla, J. M., Matute, C., Dehaye, J., & Marino, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.46.30208 · Cited by 98 · see citing works
Royle, S., Qureshi, O., Bobanović, L. K., Evans, P. R., Owen, D. J., & Murrell‐Lagnado, R. D. (2005) · Journal of Cell Science · doi:10.1242/jcs.02451 · Cited by 89 · see citing works
Moore, S., & Mackenzie, A. B. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900394 · Cited by 83 · see citing works
López‐Castejón, G., Baroja‐Mazo, A., & Pelegrı́n, P. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0609-y · Cited by 78 · see citing works
Self-citationRoger, S., Gillet, L., Baroja‐Mazo, A., Surprenant, A., & Pelegrı́n, P. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.053082 · Cited by 76 · see citing works
Self-citationCytokines and cytokine inducers stimulate prostaglandin E 2 entry into the brain
Davidson, J., Abul, H., Milton, A. S., & Rotondo, D. (2001) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240100572 · Cited by 75 · see citing works
Stimulation of rat erythrocyte P2X7receptor induces the release of epoxyeicosatrienoic acids
Jiang, H., Zhu, A. G., Mamczur, M., Falck, J. R., Lerea, K. M., & McGiff, J. C. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707311 · Cited by 73 · see citing works
Targeting Interleukin-1 Signaling in Chronic Inflammation: Focus on P2X7 Receptor and Pannexin-1
Pelegrı́n, P. (2008) · Drug News & Perspectives · doi:10.1358/dnp.2008.21.8.1265800 · Cited by 66 · see citing works
Self-citationLenertz, L. Y., Gavala, M. L., Zhu, Y., & Bertics, P. J. (2011) · Immunologic Research · doi:10.1007/s12026-011-8203-4 · Cited by 66 · see citing works
Armstrong, S., Pereverzev, A., Dixon, S. J., & Sims, S. M. (2008) · Journal of Cell Science · doi:10.1242/jcs.031534 · Cited by 56 · see citing works
Keating, C. D., Pelegrı́n, P., Martínez, C. M., & Grundy, D. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100423 · Cited by 56 · see citing works
Self-citationItoh, K., Chiang, C., Li, Z., Lee, J., Dostrovsky, J. O., & Sessle, B. J. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.06.083 · Cited by 56 · see citing works
Xia, M., & Zhu, Y. (2011) · Glia · doi:10.1002/glia.21138 · Cited by 53 · see citing works
Bartfai, T., & Conti, B. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.50 · Cited by 49 · see citing works
P2 receptor blockade attenuates fever and cytokine responses induced by lipopolysaccharide in rats
Gourine, A. V., Poputnikov, D. M., Zhernosek, N., Melenchuk, E. V., Gerstberger, R., Spyer, K. M., & Gourine, V. N. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706287 · Cited by 48 · see citing works
Nieminen, R. M., Lahti, A., Jalonen, U., Kankaanranta, H., & Moilanen, E. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2006.01.009 · Cited by 46 · see citing works
Novel P2X7 receptor antagonists ease the pain
King, B. F. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707266 · Cited by 36 · see citing works
Anrather, J., Gallo, E. F., Kawano, T., Orio, M., Abe, T., Gooden, C., Zhou, P., & Iadecola, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025916 · Cited by 36 · see citing works
Costa‐Junior, H. M., Marques-da-Silva, C., Vieira, F. S., Monção-Ribeiro, L. C., & Coutinho‐Silva, R. (2011) · Purinergic Signalling · doi:10.1007/s11302-011-9255-6 · Cited by 32 · see citing works
Eguchi, N., Kaneko, T., Urade, Y., Hayashi, H., & Hayaishi, O. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10906-3 · Cited by 32 · see citing works
Inflammasome Activation by Danger Signals
Pelegrı́n, P. (2011) · Springer eBooks · doi:10.1007/978-3-0348-0148-5_7 · Cited by 9 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
The P2X7 Receptor in Infection and Inflammation
Di Virgilio, F., Dal Ben, D., Sarti, A. C., Giuliani, A. L., & Falzoni, S. (2017) · Immunity · doi:10.1016/j.immuni.2017.06.020 · Cited by 1,267 · see citing works
Redox Regulation of NLRP3 Inflammasomes: ROS as Trigger or Effector?
Abais, J. M., Xia, M., Zhang, Y., Boini, K. M., & Li, P. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5994 · Cited by 936 · see citing works
Extracellular purines, purinergic receptors and tumor growth
Virgilio, F. D., & Adinolfi, E. (2016) · Oncogene · doi:10.1038/onc.2016.206 · Cited by 555 · see citing works
The P2X7 Receptor Channel: Recent Developments and the Use of P2X7 Antagonists in Models of Disease
Bartlett, R., Stokes, L., & Sluyter, R. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008003 · Cited by 395 · see citing works
P2X7 receptor: an emerging target in central nervous system diseases
Sperlágh, B., & Illes, P. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.08.002 · Cited by 390 · see citing works
The P2X7 receptor: A main player in inflammation
Adinolfi, E., Giuliani, A. L., De Marchi, E., Pegoraro, A., Orioli, E., & Di Virgilio, F. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.12.021 · Cited by 385 · see citing works
Purine Release, Metabolism, and Signaling in the Inflammatory Response
Linden, J. M., Koch‐Nolte, F., & Dahl, G. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052406 · Cited by 378 · see citing works
Calcium-Permeable Ion Channels in Pain Signaling
Bourinet, E., Altier, C., Hildebrand, M. E., Trang, T., Salter, M. W., & Zamponi, G. W. (2014) · Physiological Reviews · doi:10.1152/physrev.00023.2013 · Cited by 335 · see citing works
Inflammasome-dependent IL-1β release depends upon membrane permeabilisation
Martín‐Sánchez, F., Diamond, C. E., Zeitler, M., Gomez, A. I., Baroja‐Mazo, A., Bagnall, J., Spiller, D. G., White, M. H., Daniels, M. J. D., Mortellaro, A., et al. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2015.176 · Cited by 279 · see citing works
Self-citationBooshehri, L. M., & Hoffman, H. M. (2019) · Journal of Clinical Immunology · doi:10.1007/s10875-019-00638-z · Cited by 243 · see citing works
P2X7 receptor and the NLRP3 inflammasome: Partners in crime
Pelegrı́n, P. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114385 · Cited by 241 · see citing works
Self-citationThe NLRP3 and Pyrin Inflammasomes: Implications in the Pathophysiology of Autoinflammatory Diseases
de Torre‐Minguela, C., Mesa-del-Castillo, P., & Pelegrı́n, P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00043 · Cited by 239 · see citing works
Self-citationSluyter, R. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/5584_2017_59 · Cited by 235 · see citing works
Jacob, F., Perez-Novo, C. A., Bachert, C., & Crombruggen, K. V. (2013) · Purinergic Signalling · doi:10.1007/s11302-013-9357-4 · Cited by 232 · see citing works
Purinergic signaling in the immune system
Virgilio, F. D., & Vuerich, M. (2015) · Autonomic Neuroscience · doi:10.1016/j.autneu.2015.04.011 · Cited by 231 · see citing works
P2X ion channel receptors and inflammation
Burnstock, G. (2016) · Purinergic Signalling · doi:10.1007/s11302-015-9493-0 · Cited by 215 · see citing works
Accelerated Tumor Progression in Mice Lacking the ATP Receptor P2X7
Adinolfi, E., Capece, M., Franceschini, A., Falzoni, S., Giuliani, A. L., Rotondo, A., Sarti, A. C., Bonora, M., Syberg, S., Corigliano, D. M., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1259 · Cited by 177 · see citing works
Sokołowska, M., Chen, L., Liu, Y., Martínez‐Antón, A., Qi, H., Logun, C., Alsaaty, S., Park, Y. H., Kastner, D. L., Chae, J. J., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401343 · Cited by 169 · see citing works
P2X7 in Cancer: From Molecular Mechanisms to Therapeutics
Lara, R., Adinolfi, E., Harwood, C. A., Philpott, M. P., Barden, J. A., Virgilio, F. D., & McNulty, S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00793 · Cited by 165 · see citing works
Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology
Ribeiro, D. E., Oliveira-Giacomelli, Á., Glaser, T., Arnaud-Sampaio, V. F., Andrejew, R., Dieckmann, L., Baranova, J., Lameu, C., Ratajczak, M. Z., & Ulrich, H. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00965-3 · Cited by 145 · see citing works
Detecting adenosine triphosphate in the pericellular space
Falzoni, S., Donvito, G., & Di Virgilio, F. (2013) · Interface Focus · doi:10.1098/rsfs.2012.0101 · Cited by 136 · see citing works
Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors
Jelassi, B., Anchelin, M., Chamouton, J., Cayuela, M. L., Clarysse, L., Li, J., Goré, J., Jiang, L., & Roger, S. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt099 · Cited by 136 · see citing works
Gasdermins mediate cellular release of mitochondrial DNA during pyroptosis and apoptosis
de Torre‐Minguela, C., Gómez, A. I., Couillin, I., & Pelegrı́n, P. (2021) · The FASEB Journal · doi:10.1096/fj.202100085r · Cited by 136 · see citing works
Self-citationde Torre‐Minguela, C., Barberà-Cremades, M., Gómez, A. I., Martín‐Sánchez, F., & Pelegrı́n, P. (2016) · Scientific Reports · doi:10.1038/srep22586 · Cited by 131 · see citing works
Self-citationCsölle, C., Baranyi, M., Zsilla, G., Kittel, Á., Gölöncsér, F., Illes, P., Papp, E., Vizi, E. S., & Sperlágh, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066547 · Cited by 128 · see citing works
Fiebich, B. L., Akter, S., & Akundi, R. S. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00260 · Cited by 126 · see citing works
Autocrine Regulation of Macrophage Activation via Exocytosis of ATP and Activation of P2Y11 Receptor
Sakaki, H., Tsukimoto, M., Harada, H., Moriyama, Y., & Kojima, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059778 · Cited by 122 · see citing works
Gong, D., Zhang, J., Chen, Y., Xu, Y., Ma, J., Hu, G., Yi-ran, H., Zheng, J., Zhai, W., & Xue, W. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1223-y · Cited by 113 · see citing works
P2X7 Receptor as a Therapeutic Target
Marchi, E. D., Orioli, E., Ben, D. D., & Adinolfi, E. (2016) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2015.11.004 · Cited by 111 · see citing works
Killeen, M. E., Ferris, L. K., Kupetsky, E. A., Falo, L. D., & Mathers, A. R. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202045 · Cited by 109 · see citing works
Extracellular ATP and other nucleotides—ubiquitous triggers of intercellular messenger release
Zimmermann, H. (2015) · Purinergic Signalling · doi:10.1007/s11302-015-9483-2 · Cited by 105 · see citing works
Roger, S., Jelassi, B., Couillin, I., Pelegrı́n, P., Besson, P., & Jiang, L. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.10.029 · Cited by 101 · see citing works
Self-citationIon homeostasis and ion channels in NLRP3 inflammasome activation and regulation
Hafner‐Bratkovič, I., & Pelegrı́n, P. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.03.010 · Cited by 94 · see citing works
Self-citationAlves, L. A., Soares‐Bezerra, R. J., Faria, R. X., Ferreira, L., & Frutuoso, V. D. S. (2013) · Molecules · doi:10.3390/molecules180910953 · Cited by 92 · see citing works
Modulation of innate and adaptive immunity by P2X ion channels
Virgilio, F. D., Sarti, A. C., & Grassi, F. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.03.026 · Cited by 89 · see citing works
Ectonucleotidases in Acute and Chronic Inflammation
Giuliani, A. L., Sarti, A. C., & Virgilio, F. D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.619458 · Cited by 78 · see citing works
Ursu, D., Ebert, P. J., Langron, E., Ruble, C., Munsie, L. M., Zou, W., Fijal, B. A., Qian, Y., McNearney, T. A., Mogg, A. J., et al. (2014) · Molecular Pain · doi:10.1186/1744-8069-10-37 · Cited by 77 · see citing works
Emerging role of P2X7 receptors in CNS health and disease
Tewari, M., & Seth, P. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.10.001 · Cited by 74 · see citing works
Barberà-Cremades, M., Gómez, A. I., Baroja‐Mazo, A., Martínez-Alarcón, L., Martínez, C. M., de Torre‐Minguela, C., & Pelegrı́n, P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00862 · Cited by 71 · see citing works
Self-citationToki, Y., Takenouchi, T., Harada, H., Tanuma, S., Kitani, H., Kojima, S., & Tsukimoto, M. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.02.011 · Cited by 70 · see citing works
Imaging extracellular ATP with a genetically-encoded, ratiometric fluorescent sensor
Conley, J. M., Radhakrishnan, S., Valentino, S. A., & Tantama, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187481 · Cited by 69 · see citing works
Regulation of Hemichannels and Gap Junction Channels by Cytokines in Antigen-Presenting Cells
Sáez, P. J., Shoji, K. F., Aguirre, A., & Sáez, J. C. (2014) · Mediators of Inflammation · doi:10.1155/2014/742734 · Cited by 68 · see citing works
Chaves, M. M., Marques-da-Silva, C., Monteiro, A. P. T., Canetti, C. D. A., & Coutinho‐Silva, R. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301058 · Cited by 67 · see citing works
Sathanoori, R., Swärd, K., Olde, B., & Erlinge, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125111 · Cited by 66 · see citing works
Li, J.-M., Deng, H., Yao, Y.-D., Wang, W., Hu, J.-Q., Dong, Y., Wang, P., Liu, L., Liu, Z., Xie, Y., et al. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-023-01124-4 · Cited by 61 · see citing works
Understanding the role of P2X7 in affective disorders—are glial cells the major players?
Stokes, L., Spencer, S. J., & Jenkins, T. A. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00258 · Cited by 58 · see citing works
Stockwell, M. S., Broder, K. R., LaRussa, P. S., Lewis, P., Fernandez, N., Sharma, D., Barrett, A. E., Sosa, J., & Vellozzi, C. J. (2014) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2013.4469 · Cited by 56 · see citing works
Fan, Z., Zhang, Y., Yi-hong, G., Huang, N., Ma, H., Huang, H., & Yu, H. (2016) · Scientific Reports · doi:10.1038/srep35804 · Cited by 56 · see citing works
Zhong, S., Zhou, Z., Liang, Y., Cheng, X., Li, Y., Teng, W., Zhao, M., Liu, C., Guan, M., & Zhao, C. (2019) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2019.1608905 · Cited by 56 · see citing works
Mishra, A., Behura, A., Kumar, A., Naik, L., Swain, A., Das, M., Sarangi, S. S., Dokania, P., Dirisala, V. R., Bhutia, S. K., et al. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174235 · Cited by 53 · see citing works
Huang, T., Lai, H., Chen, Y.-B., Chen, L.-G., Wu, Y., Ko, Y., Lu, C., Chang, C., Wu, C.-Y., Martel, J., et al. (2013) · Innate Immunity · doi:10.1177/1753425913507096 · Cited by 52 · see citing works
ATP and adenosine: Role in the immunopathogenesis of rheumatoid arthritis
da Silva, J. L. G., Passos, D. F., Bernardes, V. M., & Leal, D. B. R. (2019) · Immunology Letters · doi:10.1016/j.imlet.2019.08.009 · Cited by 51 · see citing works
Gonzaga, D. T. G., Ferreira, L. B. G., Costa, T. E. M. M., von Ranke, N. L., Pacheco, P. A. F., Simões, A., Arruda, J. C., Dantas, L. P., Freitas, H. R., Reis, R. A. D. M., et al. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.08.034 · Cited by 49 · see citing works
Genetic variation in P2RX7 and pain tolerance
Kambur, O., Kaunisto, M. A., Winsvold, B. S., Wilsgaard, T., Stubhaug, A., Zwart, J., Kalso, E. A., & Nielsen, C. S. (2018) · Pain · doi:10.1097/j.pain.0000000000001188 · Cited by 49 · see citing works
CD14 release induced by P2X7 receptor restricts inflammation and increases survival during sepsis
Alarcón‐Vila, C., Baroja‐Mazo, A., de Torre‐Minguela, C., Martínez, C. M., Martínez-García, J. J., Martínez‐Banaclocha, H., García-Palenciano, C., & Pelegrı́n, P. (2020) · eLife · doi:10.7554/elife.60849 · Cited by 48 · see citing works
Self-citationNovel biologics targeting the P2X7 ion channel.
Koch-Nolte, F., Eichhoff, A., Pinto-Espinoza, C., Schwarz, N., Schäfer, T., Menzel, S., Haag, F., Demeules, M., Gondé, H., & Adriouch, S. (2019) · Current opinion in pharmacology (Print) · doi:10.1016/j.coph.2019.03.001 · Cited by 44 · see citing works
P2X7 receptor activation leads to NLRP3-independent IL-1β release by human macrophages
Bockstiegel, J., Engelhardt, J., & Weindl, G. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01356-1 · Cited by 45 · see citing works
Chen, J., Zhao, Y., & Liu, Y. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00656 · Cited by 43 · see citing works
Inflammasome Activation Induced by a Snake Venom Lys49-Phospholipase A2 Homologue
Boeno, C. N., Paloschi, M. V., Lopes, J. A., Pires, W. L., Setúbal, S. D. S., Evangelista, J. R., Soares, A. M., & Zuliani, J. P. (2019) · Toxins · doi:10.3390/toxins12010022 · Cited by 42 · see citing works
The P2X7 Receptor in Osteoarthritis
Li, Z., Huang, Z., & Bai, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.628330 · Cited by 42 · see citing works
P2X7 Receptor Function in Bone-Related Cancer
Adinolfi, E., Amoroso, F., & Giuliani, A. L. (2012) · Journal of Osteoporosis · doi:10.1155/2012/637863 · Cited by 41 · see citing works
Tajbakhsh, A., Pasdar, A., Rezaee, M., Fazeli, M., Soleimanpour, S., Hassanian, S. M., FarshchiyanYazdi, Z., Rad, T. Y., Ferns, G. A., & Avan, A. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26277 · Cited by 40 · see citing works
P2X7 receptor in cardiovascular disease: The heart side
Martinez, C. G. (2019) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13079 · Cited by 40 · see citing works
Schachter, J., Guijarro, A., Angosto-Bazarra, D., Pinilla, M., Hurtado‐Navarro, L., Meunier, É., Pérez‐Oliva, A. B., Schwarzbaum, P. J., & Pelegrı́n, P. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115233 · Cited by 39 · see citing works
Self-citationGarré, J. M., Silva, H. M., Lafaille, J. J., & Yang, G. (2020) · Nature Communications · doi:10.1038/s41467-020-15590-5 · Cited by 39 · see citing works
Baroja‐Mazo, A., & Pelegrı́n, P. (2012) · Journal of Osteoporosis · doi:10.1155/2012/408242 · Cited by 38 · see citing works
Self-citationD’Alimonte, I., Nargi, E., Zuccarini, M., Lanuti, P., Iorio, P. D., Giuliani, P., Ricci‐Vitiani, L., D, R. P. M., Caciagli, F., & Ciccarelli, R. (2015) · Purinergic Signalling · doi:10.1007/s11302-015-9454-7 · Cited by 37 · see citing works
Shimada, H., Nakamura, Y., Nakanishi, T., & Tamai, I. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.10.009 · Cited by 36 · see citing works
Involvement of P2X7 receptor in neuronal degeneration triggered by traumatic injury
Nadal-Nicolás, F. M., Galindo‐Romero, C., Valiente‐Soriano, F. J., Barberà-Cremades, M., de Torre‐Minguela, C., Salinas‐Navarro, M., Pelegrı́n, P., & Agudo‐Barriuso, M. (2016) · Scientific Reports · doi:10.1038/srep38499 · Cited by 35 · see citing works
Self-citationThe role of microglia and P2X7 receptors in gliomas
Kan, L. K., Williams, D. J., Drummond, K. J., O'Brien, T. J., & Monif, M. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.04.010 · Cited by 35 · see citing works
Calzaferri, F., Narros‐Fernández, P., de Pascual, R., de Diego, A. M. G., Nicke, A., Egea, J., de Diego, A. M. G., & Rı́os, C. D. L. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c02145 · Cited by 35 · see citing works
The contribution of ion channels to shaping macrophage behaviour
Selezneva, A. I., Gibb, A. J., & Willis, D. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.970234 · Cited by 32 · see citing works
P2X7 receptor deletion suppresses γ-radiation-induced hyposalivation
Gilman, K. E., Camden, J. M., Klein, R. R., Zhang, Q., Weisman, G. A., & Limesand, K. H. (2019) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00192.2018 · Cited by 32 · see citing works
Baroja‐Mazo, A., Compan, V., Martín‐Sánchez, F., Tapia‐Abellán, A., Couillin, I., & Pelegrı́n, P. (2019) · Scientific Reports · doi:10.1038/s41598-019-42298-4 · Cited by 30 · see citing works
Self-citationCrosstalk between purinergic receptors and lipid mediators in leishmaniasis
Chaves, M. M., Canetti, C. D. A., & Coutinho‐Silva, R. (2016) · Parasites & Vectors · doi:10.1186/s13071-016-1781-1 · Cited by 28 · see citing works
Modulating ion channel function with antibodies and nanobodies
Stortelers, C., Pinto-Espinoza, C., Hoorick, D. V., & Koch‐Nolte, F. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.02.003 · Cited by 27 · see citing works
Lucas‐Ruiz, F., Agudo‐Barriuso, M., Galindo‐Romero, C., Albaladejo‐García, V., & Vidal‐Sanz, M. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.310670 · Cited by 26 · see citing works
Li, X., Mazaleuskaya, L. L., Ballantyne, L. L., Meng, H., FitzGerald, G. A., & Funk, C. D. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m080028 · Cited by 26 · see citing works
P2X7 receptor as the regulator of T-cell function in intestinal barrier disruption
Jiang, Z., Wu, W. H., Hu, H.-B., Li, Z., Zhong, M., & Zhang, L. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i36.5265 · Cited by 25 · see citing works
Co-Expression of Wild-Type P2X7R with Gln460Arg Variant Alters Receptor Function
Aprile-Garcia, F., Metzger, M. W., Páez-Pereda, M., Stadler, H., Acuña, M., Liberman, A. C., Senin, S. A., Gerez, J., Hoijman, E., Refojo, D., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151862 · Cited by 25 · see citing works
Fliegert, R., Heeren, J., Koch‐Nolte, F., Nikolaev, V. O., Lohr, C., Meier, C., & Guse, A. H. (2019) · Biochemical Society Transactions · doi:10.1042/bst20180419 · Cited by 25 · see citing works
Purinergic receptors and the inflammatory response mediated by lipids
Alarcón‐Vila, C., Pizzuto, M., & Pelegrı́n, P. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.02.004 · Cited by 25 · see citing works
Self-citationEndo, Y., Blinova, K., Romantseva, T., Golding, H., & Zaitseva, M. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098517 · Cited by 25 · see citing works
Manfredini, M., Giuliani, A. L., Ruina, G., Gafà, R., Bosi, C., Zoppas, E., Virgilio, F. D., & Bettoli, V. (2019) · Dermatology · doi:10.1159/000502026 · Cited by 25 · see citing works
Lack of chemopreventive effects of P2X7R inhibitors against pancreatic cancer
Mohammed, A., Janakiram, N. B., Madka, V., Pathuri, G., Li, Q., Ritchie, R. L., Biddick, L., Kutche, H., Zhang, Y., Singh, A. K., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22085 · Cited by 24 · see citing works
Boeno, C. N., Paloschi, M. V., Lopes, J. A., Souza Silva, M. D., Evangelista, J. R., dos Reis, V. P., da S. Setúbal, S., Soares, A. M., & Zuliani, J. P. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109194 · Cited by 24 · see citing works
Través, P. G., Pimentel-Santillana, M., Carrasquero, L. M. G., Pérez‐Sen, R., Delicado, E. G., Luque, A., Izquierdo, M., Martín‐Sanz, P., Miras‐Portugal, M. T., & Boscá, L. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203029 · Cited by 24 · see citing works
Impact of FDA-Approved Drugs on the Prostaglandin Transporter OATP2A1/SLCO2A1
Kamo, S., Nakanishi, T., Aotani, R., Nakamura, Y., Gose, T., & Tamai, I. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.04.046 · Cited by 23 · see citing works
Dai, X., Fang, X., Xia, Y., Li, M., Li, X., Wang, Y., Tao, J., & Li, X.-P. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s351660 · Cited by 22 · see citing works
P2X7 receptor activation impairs antitumour activity of natural killer cells
Baroja‐Mazo, A., Peñín‐Franch, A., Lucas‐Ruiz, F., de Torre‐Minguela, C., Alarcón‐Vila, C., Hernández‐Caselles, T., & Pelegrı́n, P. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15951 · Cited by 22 · see citing works
Self-citationR270C polymorphism leads to loss of function of the canine P2X7 receptor
Spildrejorde, M., Bartlett, R., Stokes, L., Jalilian, I., Peranec, M., Sluyter, V., Curtis, B. L., Skarratt, K. K., Skora, A. S., Bakhsh, T., et al. (2014) · Physiological Genomics · doi:10.1152/physiolgenomics.00195.2013 · Cited by 22 · see citing works
P2X7 receptor in skin biology and diseases
Geraghty, N. J., Watson, D., Adhikary, S. R., & Sluyter, R. (2016) · World Journal of Dermatology · doi:10.5314/wjd.v5.i2.72 · Cited by 21 · see citing works
Xu, X., Pocock, G. M., Sharma, A., Peery, S. L., Fites, J. S., Felley, L. E., Żarnowski, R., Stewart, D., Berthier, E., Klein, B. S., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.061 · Cited by 21 · see citing works
Regulation of ATP-Gated P2X Channels: From Redox Signaling to Interactions with Other Proteins
Stojilković, S. S., Leiva‐Salcedo, E., Rokic, M. B., & Coddou, C. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5549 · Cited by 21 · see citing works
Mittal, R., Chan, B., Grati, M., Mittal, J., Patel, K., Debs, L. H., Patel, A. P., Yan, D. L. S., Chapagain, P. P., & Liu, X. Z. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25274 · Cited by 21 · see citing works
Isolation of functional mature peritoneal macrophages from healthy humans
Ruiz‐Alcaraz, A. J., Martínez‐Banaclocha, H., Marín‐Sánchez, P., Carmona‐Martínez, V., Iniesta‐Albadalejo, M. A., Tristán‐Manzano, M., Tapia‐Abellán, A., García–Peñarrubia, P., Machado‐Linde, F., Pelegrı́n, P., et al. (2019) · Immunology and Cell Biology · doi:10.1111/imcb.12305 · Cited by 20 · see citing works
Self-citationXie, F., Xu, L., Zhu, H., Chen, Y., Li, Y., Nong, L., Zeng, Y., & Cen, S. (2022) · Molecules · doi:10.3390/molecules27082465 · Cited by 19 · see citing works
Zou, Y.-T., Li, J., Chai, J.-Y., Hu, Y., Zhang, W., & Zhang, Q. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.149513 · Cited by 18 · see citing works
Davis, C. J., Taishi, P., Honn, K. A., Koberstein, J. N., & Krueger, J. M. (2016) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00167.2016 · Cited by 18 · see citing works
Meyer, L., Leymarie, O., Chevalier, C., Esnault, E., Moroldo, M., da Costa, B. R., Georgeault, S., Roingeard, P., Delmas, B., Quéré, P., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176355 · Cited by 18 · see citing works
- Authors
- Barberà‐Cremades, M., Baroja‐Mazo, A., Gomez, A. I., Machado, F., Di Virgilio, F., & Pelegrín, P.
- Affiliations
- Inflammation and Experimental Surgery Unit Centro de Investigación Biomédica en Red de Enfermedades Hepaticas y Digestivas (CIBERhed)
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (ES)
- Hospital Universitario Virgen de la Arrixaca (ES)
- Section of General Pathology, Department of Experimental and Diagnostic Medicine University of Ferrara Ferrara Italy
- ORCID
- Baroja‐Mazo, Alberto
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2012-04-06
- Volume
- 26
- Issue
- 7
- Pages
- 2951-2962
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2147692999
- Cited by
- 142
- References
- 62
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 7 · 2023: 5 · 2022: 9 · 2021: 11 · 2020: 5 · 2019: 18 · 2018: 4 · 2017: 16 · 2016: 13 · 2015: 12 · 2014: 17 · 2013: 11 · 2012: 3
- FWCI
- 9.66
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Hispana (publishedVersion, cc-by-nc-nd)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Physiology › Pain Mechanisms and Treatments
- Keywords
- P2X7 receptor, fever, prostaglandin E2, IL-1β, extracellular ATP, inflammasome, lipopolysaccharide, endogenous pyrogen, P2X7 receptor antagonists, acute inflammation, inflammatory pain, autacoids
- MeSH terms
- Adenosine Triphosphate, Animals, Fever, Humans, Injections, Intraperitoneal, Leukotriene B4, Lipopolysaccharides, Macrophages, Mice, Inbred C57BL, Recombinant Proteins, Thromboxane B2, Dinoprostone, Mice, Knockout, Inflammation Mediators, Calcium Signaling, MAP Kinase Signaling System, Mice, Cyclooxygenase 2, Interleukin-1beta, Receptors, Purinergic P2X7, Receptors, Purinergic P2X4, Purinergic P2X Receptor Agonists, Purinergic P2X Receptor Antagonists, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review